Amikacin was applied clinically to 10 cases of various infections in the field of internal medicine.
The results obtained were effective in 5 (including markedly effective cases), moderately effective in 3 and ineffective in 2.
No side effects were observed in any of all the cases.
In comparison between the antibacterial activities of amikacin and KM against the clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus, amikacin was more active than KM but slightly less active than GM and DKB.